Aerie Em

11/12/2019

SAG meeting held at IVI followed by second face-to-face BOT meeting of the year

On November 12, 2019, IVI’s Scientific Advisory Group (SAG) gathered at IVI headquarters in Seoul, Korea for an annual two-day meeting of project presentations, insightful Q&As, and critical engagement. Following the SAG days, the IVI Board of Trustees met for their second face-to-face meeting of […]
11/04/2019

IVI acquires GCLP certification from Korean Ministry of Food and Drug Safety

Institute expected to increase contributions to vaccine development activities worldwide   November 1, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI), an international organization for vaccine development and delivery headquartered in Seoul, has been granted Good Clinical Laboratory Practice (GCLP) certification by […]
10/31/2019

8th UN Secretary-General Ban Ki-moon delivers congratulatory remarks during IVI State Forum 2019

IVI hosted a State Forum at their headquarters in Seoul on Friday, October 11, showcasing the impact of international cooperation in vaccine research and development (R&D), and delivery in low- and middle-income countries. The Forum was attended by ambassadors and senior diplomats from 17 countries, […]
10/29/2019

IVI Awarded $4.5 Million Grant to Increase Accessibility of Oral Cholera Vaccine

October 28, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI) has received a $4.5 million grant from the Bill & Melinda Gates Foundation to simplify the current oral cholera vaccine (OCV) and further increase its accessibility. To date, the Gates Foundation has […]